Naslov
Occluded superior mesenteric artery and vein. Therapy with the stable gastric pentadecapeptide BPC 157

Autori
Knežević, Mario ; Gojković, Slaven ; Krezić, Ivan ; Žižek, Helena ; Malekinušić, Dominik ; Vrdoljak, Borna ; Knežević, Tamara ; Vraneš, Hrvoje ; Drmić, Domagoj ; Staroveški, Miro ; Đuzel, Antonija ; Rajković, Zoran ; Kolak, Toni ; Lovrić, Eva ; Milavić, Marija ; Sikirić, Sunčana ; Tvrdeić, Ante ; Patrlj, Leonardo ; Štrbe, Sanja ; Šola, Marija ; Šitum, Andrej ; Kokot, Antonio ; Boban Blagai, Alemska ; Škrtić, Anita ; Seiwerth, Sven ; Sikirić, Predrag

Izvornik
Biomedicines (2227-9059) 9 (2021), 7; 792, 26

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni

Ključne riječi
BPC 157 ; rats ; superior mesenteric vein and artery occlusion ; vascular recruitment

Sažetak
Background: We investigated the occluded essential vessel tributaries, both arterial and venous, occluded superior mesenteric vein and artery in rats, consequent noxious syndrome, peripherally and centrally. As therapy, we hypothesized the rapidly activated alternative bypassing pathways, arterial and venous, and the stable gastric pentadecapeptide BPC 157 since it rapidly alleviated venous occlusion syndromes. Methods: Assessments were performed for 30 min (gross recording, venography, ECG, pressure, microscopy, biochemistry, and oxidative stress), including portal hypertension, caval hypertension, aortal hypotension, and centrally, the superior sagittal sinus hypertension ; systemic arterial and venous thrombosis, ECG disturbances, MDA-tissue increase, the multiple organs lesions, heart, lung, liver, kidney and gastrointestinal tract, including brain (swelling, and cortex (cerebral, cerebellar), hypothalamus/thalamus, hippocampus lesions). Rats received BPC 157 medication (10 µg/kg, 10 ng/kg) intraperitoneally at 1 min ligation-time. Results: BPC 157 rapidly activated collateral pathways. These collateral loops were the superior mesenteric vein-inferior anterior pancreaticoduodenal vein-superior anterior pancreaticoduodenal vein-pyloric vein-portal vein pathway, an alternative pathway toward inferior caval vein via the united middle colic vein and inferior mesenteric vein through the left colic vein, and the inferior anterior pancreaticoduodenal artery and inferior mesenteric artery. Consequently, BPC 157 counteracted the superior sagittal sinus, portal and caval hypertension, aortal hypotension, progressing venous and arterial thrombosis peripherally and centrally, ECG disturbances attenuated. Markedly, the multiple organs lesions, heart, lung, liver, kidney, and gastrointestinal tract, in particular, as well as brain lesions, and oxidative stress in tissues were attenuated. Conclusions: BPC 157 therapy rapidly recovered rats, which have complete occlusion of the superior mesenteric vein and artery.

Izvorni jezik
Engleski

Znanstvena područja
Temeljne medicinske znanosti, Kliničke medicinske znanosti

POVEZANOST RADA